CIK 0001137883 · Non-accelerated filer<br>Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 207273918
- Phone
- 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-10 | Lebovits Chaim President & CEO | Purchase | +20,000 | $0.47 | $9K | 1,079,865 |
| 2024-05-10 | Lebovits Chaim President & CEO | Grant or award | +20,000 | $0.47 | $9K | 1,079,865 |
| 2024-05-07 | Lebovits Chaim President & CEO | Purchase | +66,300 | $0.37 | $25K | 1,059,865 |
| 2024-05-07 | Lebovits Chaim President & CEO | Grant or award | +66,300 | $0.37 | $25K | 1,059,865 |
| 2024-05-06 | Lebovits Chaim President & CEO | Purchase | +135,000 | $0.38 | $51K | 993,565 |
| 2024-05-06 | Lebovits Chaim President & CEO | Grant or award | +135,000 | $0.38 | $51K | 993,565 |
| 2024-04-19 | Lebovits Chaim President & CEO | Purchase | +15,000 | $0.52 | $8K | 858,565 |
| 2024-04-19 | Lebovits Chaim President & CEO | Grant or award | +15,000 | $0.52 | $8K | 858,565 |
| 2024-04-18 | Lebovits Chaim President & CEO | Purchase | +115,072 | $0.53 | $60K | 843,565 |
| 2024-04-18 | Lebovits Chaim President & CEO | Grant or award | +115,072 | $0.53 | $60K | 843,565 |
| 2024-04-17 | Lebovits Chaim President & CEO | Purchase | +130,000 | $0.55 | $71K | 728,493 |
| 2024-04-17 | Lebovits Chaim President & CEO | Grant or award | +130,000 | $0.55 | $71K | 728,493 |
| 2024-03-11 | Lindborg Stacy Co-Chief Executive Officer | Grant or award | +241,935 | 423,435 | ||
| 2024-03-11 | Yablonka Uri EVP & Chief Business Officer | Grant or award | +109,426 | 126,969 | ||
| 2024-03-11 | Patlis Alla See Remarks | Grant or award | +65,246 | 65,246 | ||
| 2024-03-11 | Lebovits Chaim President & CEO | Grant or award | +305,198 | 598,493 | ||
| 2023-09-01 | Lindborg Stacy Co-Chief Executive Officer | Purchase | +11,500 | $1.77 | $20K | 181,500 |
| 2023-08-02 | Lindborg Stacy Co-Chief Executive Officer | Grant or award | +35,000 | 170,000 | ||
| 2023-08-02 | Lebovits Chaim President & CEO | Grant or award | +31,185 | 293,295 | ||
| 2023-06-19 | Naor Nir Director | Grant or award | +11,999 | 11,999 |
Page 3 of 7 · 127 trades